P. Clingan

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years

Armand de Gramont, C. Boni, Matilde Navarro et al. · Journal of Clinical Oncology · 2007 · 129 citations

Medicine, Oncology, Chemotherapy +16

Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years

Armand de Gramont, C. Boni, Matilde Navarro et al. · Journal of Clinical Oncology · 2005 · 117 citations

Medicine, Oncology, Pharmacology +17

Percutaneous Imaging–Guided Radiofrequency Ablation in Patients With Colorectal Pulmonary Metastases: 1-Year Follow-Up

Karin Steinke, Derek Glenn, Julie King et al. · Annals of Surgical Oncology · 2004 · 114 citations

Medicine, Oncology, Surgery +14

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

E. Gabriela Chiorean, Daniel D. Von Hoff, Michele Reni et al. · Annals of Oncology · 2016 · 103 citations · Full text

Medicine, Oncology, Pharmacology +12